Medpace Holdings Inc expected to post earnings of $2.54 a share - Earnings Preview

Medpace Holdings

19/07/2024 21:41

* Medpace Holdings Inc  MEDP.OQ   MEDP.O  is expected
to show a
rise in quarterly revenue when it reports  results on July 22
for the period ending June 30 2024
    * The Cincinnati Ohio-based  company is expected to report a
14.7% increase in revenue to $528.44 million from $460.87
million a year ago, according to the mean estimate from 8
analysts, based on LSEG data. (SAL consensus is on Total revenue
basis.)
    * ​LSEG's mean analyst estimate for Medpace Holdings Inc is
for
earnings of $2.54 per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Medpace
Holdings
Inc is $451.00​, above​ its last closing price of $423.96. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Mar. 31 2024  2.47        2.47       3.20      Beat    29.8
 Jan. 1 2024   2.22        2.22       2.46      Beat    10.7
 Sep. 30 2023  2.04        2.05       2.22      Beat    8.5​
 Jun. 30 2023  1.91        1.91       1.93      Beat    0.8
 ​​Mar.        1.80        1.80       2.27      Beat    26
 31 2023                                                
 Dec. 31 2022  1.79        1.79       2.12      Beat    18.7​
 Sep. 30 2022  1.48        1.47       2.05      Beat    39.1
 Jun. 30 2022  1.33        1.31       1.46      Beat    11.3
 This summary was machine generated July 19 at 20:41 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)